Navigation Links
RSB Spine, LLC, Announces Sales Increases of 38% Year Over Year, 42% Sequentially: Reaches InterPlate(R) Implantation Milestone
Date:1/8/2010

CLEVELAND, Jan. 8 /PRNewswire/ -- RSB Spine, LLC, today announced a 38% increase in sales for year ended Dec. 31, 2009, versus year-end 2008, and a 42% sales increase for the fourth quarter of 2009 versus third-quarter 2009. Additionally, the company reported that it achieved an important milestone in 2009 with its 1,000th InterPlate® product being implanted.

RSB Spine Chief Executive Officer John A. Redmond said: "We are obviously delighted with our strong sales performance both year over year and sequentially, which we attribute to be the direct result of the master distribution agreement signed with Paradigm BioDevices in October 2009. We are also very pleased to have achieved the significant milestone of having our products implanted in more than 1,000 patients with excellent results."

RSB Spine is a privately held medical device company focused on developing innovative spinal implants with a focus on modular fusion products. News releases and other information on the company are available on the Internet at: http://www.rsbspine.com.

SOURCE RSB Spine

RELATED LINKS
http://www.rsbspine.com

'/>"/>

SOURCE RSB Spine
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. RSB Spine, LLC Announces FDA Clearance of New InterPlate(TM) Indications
2. Medtronic Spine, Formerly Kyphon Inc., to Pay U.S. $75 Million to Resolve Allegations Of Defrauding Medicare
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , ... March 29, 2017 , ... HealthCareMandA.com will host ... April 20, 2017, at 1:00 PM ET. A recording of the webinar will also ... Webinar Series. , Home health and hospice companies are still popular targets for healthcare ...
(Date:3/29/2017)... North Hollywood, CA (PRWEB) , ... March 29, 2017 , ... ... and Northridge , is now offering laser dental treatments. Dental lasers are safe ... treatments. Laser dentistry expands patients’ options and can improve the overall quality of care. ...
(Date:3/29/2017)... ... 2017 , ... The Wharton School of the University of Pennsylvania is pleased ... a $10 million gift to establish the Ken Moelis and Julie Taffet Moelis ... a Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests expand traditional ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... assumption that in order to improve teacher quality, the field must first improve ... from one popular reform to the next” and that decades of input- and ...
(Date:3/28/2017)... YORK, NEW YORK (PRWEB) , ... March 28, ... ... breakthrough development, NTX Technology™, is the first technology to directly address the resolution ... Health Organization. NTX Technology™ is a patented compound of FDA and TTB approved ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)...  Las Vegas ophthalmology practice, Center For Sight, announced ... Dublin ), an implant that shunts ... intraocular pressure in patients with moderate to severe glaucoma. ... glaucoma that can lead to progressive optic nerve damage ... untreated. According to the National Eye Institute, ...
(Date:3/28/2017)... 2017 The U.S. Food and Drug ... adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is ... adequately by topical therapies, or those for whom ... used with or without topical corticosteroids. ... approving new and innovative therapies for patients with ...
(Date:3/28/2017)... LONDON , March 28, 2017  "US ... insight on the various indicators and trend analysis ... generics drugs in mainstream pharmaceutical market in US. ... responsible for the growth on cancer generics drugs ... resulted in saving of billions of dollars for ...
Breaking Medicine Technology: